Infection Control Market

Infection Control Market Size (2023 to 2028)

The global infection control market size is forecasted to be worth USD 88.1 billion by 2028 from USD 49.1 billion in 2023, registering a CAGR of 12.4% from 2023 to 2028.

Infection Control Market Share Insights:

• Based on products and services, the cleaning and disinfection segment dominated the infection control market in 2021.
• Based on the end-user, the hospital segment led the infection control market and accounted for a global market share of 32.8% in 2021.
• North America captured a global market share of 36.8% in 2021.
• The European market is anticipated to be worth USD 22.7 billion by 2027.
• The Asia-Pacific region is expected to grow at a CAGR of 14.44% from 2022 to 2027.

Infection control is related to inhibiting the process of the spread of infections. Infection control is done for public safety even with limited resources in many emerging countries but still infected by deadly diseases. The infection control market covers products and services for cleaning, sterilization, and disinfecting in hospitals, clinics, etc. The infection can vary from usual skin-related issues to deadly organ dysfunction; thus, the control measures are also very different.

MARKET DRIVERS:

The growing global geriatric population and rising incidence of life-threatening diseases such as obesity, cancer, diabetes, and respiratory and cardiac conditions propel the global infection control market growth.

As per the statistics published by the World Health Organization (WHO), the number of people above 60 years was 1 billion in 2020, and this number is expected to grow to 1.4 billion by 2030 and 2.1 billion by 2050. In addition, the introduction of stringent government policies to control the degree of infections and the rapid rise in technological advancements are favoring the infection control market. Technological awareness regarding these products and services, infrastructural development from different hospitals and healthcare facilities in developing regions, and a greater emphasis on food sterilization are some other factors that promote market growth.

The rise in the number of people suffering from hospital-acquired infections (HAIs) is another major factor promoting the infection control market growth.

Now, hospitals do complete sterilization and cleaning to prevent the spread of the virus among patients. In addition, growing surgical procedures and international medical instruments processing propel the growth of the infection control market worldwide. An estimated 1.7 million patients are getting affected by HAIs every year while taking treatments in hospitals, the U.S. Centre for Disease Control and Prevention observed. Furthermore, the global infection control market is driven by the geriatric population in countries with low hygiene standards leading to more infections, thus increasing demand for infection control products and services.

The adoption of new technologies and advances in infection control system technology, growing awareness about cleaning and disinfectant conditions, rising requirements for successful cleaning, and the recent coronavirus epidemic (COVID-19) provide lucrative growth opportunities to the global infection control market. In addition, public demand to increase hospital care quality, the increasing cost of HAIs (Hospital-acquired infections) in healthcare facilities, and the rise of multi-drug-resistant microorganisms lead to the development of the infection control market.

MARKET RESTRAINTS:

Factors such as public awareness of harmful infections and the benefits of infection control processes and products hinder the infection control market growth. Furthermore, health department guidance for non-developed countries is still unclear among the population, resulting in a disregard for infection prevention procedures and inhibiting the growth of the infection control market. In addition, concerns about the protection of processed surgical instruments were hazardous for patients, healthcare staff, or clinicians, resulting in infection spread, thereby serving as a restriction factor for the infection control market.

In addition, manufacturers must deal with kit storage problems if the sterile environment is maintained. This also makes it difficult for new players to enter the infection control market, challenging the industry. Cleaning, disinfection, and sterilization of modern surgical instruments are all causes of risk. Patients may risk contracting HAIs if these instruments are not sterilized and appropriately disinfected. Inadequate disinfection of these complex and sensitive instruments will put patients at risk for infection. 

COVID-19 impact on the global infection control market:

With the severe outbreak of COVID-19, there is a massive demand for products and the process of infection control. There is a global demand for advanced healthcare facilities, services, and infrastructure to treat the infected. In healthcare, the need for Personal protection equipment or PPE kits has increased due to increased usage from doctors, health personnel, and infection control workers. Healthcare workers rely on PPE kits to protect themselves and patients from infections. The COVID-19 outbreak has also resulted in a surge in demand for face masks and gloves worldwide, but the industry cannot fulfill it and create a gap between supply and demand due to the sudden increase.

REPORT COVERAGE:

This research report on the global infection control market has been segmented and sub-segmented based on Products and Services, end-user, and regions.

Infection Control Market – By Products and Services:

• Cleaning and Disinfection Products
• Sterilization Products and Services
• Endoscope Reprocessing Products
• Protective Equipment
• Others

The cleaning and disinfection products segment is estimated to account for the largest share among all segments based on the products and services. It is expected to register a stable growth rate during the forecast period. The growth is attributed to the increase in awareness among people about the effects of deadly infections. During the COVID-19 period, governments have popularized campaigns showing such products' benefits, thus increasing their popularity. As a result, companies are investing more to make more effective products and make people more aware of them.

The Sterilization products segment is predicted to be the second largest among all and is expected to grow at a decent market rate from 2023 to 2028. The increase in surgical procedures has driven this market as medical practitioners and patients have become more aware of the disadvantages of unhygienic medical instruments and how they can act as infection spreaders.

In 2022, the protective equipment segment was the third-leading segment but was expected to grow at the highest growth rate during the forecast period. The COVID-19 virus is a significant reason to drive growth, and there is a massive demand for personal protective equipment and face masks. The increasing demand has also led to more innovation in face mask material. In addition, governments worldwide have encouraged new players to enter the market as the current supply cannot fulfill the demand. This introduction of new players has driven the growth of this segment exponentially.

The endoscope reprocessing segment is expected to grow significantly as awareness about the benefits increases. Endoscope reprocessing means reprocessing the instruments and equipment used in endoscopy procedures to not act as an infection carrier.

Infection Control Market – By End-User:

• Hospitals and clinics
• Medical device companies
• Pharmaceutical companies
• Life sciences companies
• Food Industry
• Others

Based on the end-user, the Hospitals and clinics held the largest market share in 2022. With the COVID-19 pandemic currently, the growth of this segment is expected to rise at the highest rate as there is more need for protective equipment and cleaning products to hinder the spread of viruses.

Companies that manufacture medical devices now use infection control processes and products to make the devices infection-free to not act as carriers for the doctors and patients. More and more research is being done to maintain and produce effective products that are less expensive. As a result, it has the second-largest market share and is expected to have profitable growth in the forecast period.

Pharmaceutical companies are now more advanced in infection control due to their experience in the early days of the COVID-19 outbreak. As a result, they have the third-largest market share and are expected to have steady growth.

The life sciences and food industry have the fifth and sixth most significant market share among all segments and are expected to have profitable growth in the forecast period. High safety standards requirements by governments are the primary driver for these segments.

Infection Control Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Regionally, the Asia Pacific region is expected to showcase the highest CAGR in the global market during the forecast period among all the regions. Countries such as India and China have the highest population and population growth worldwide, which majorly regulates the market growth in this region. The developing countries are now focusing on hygiene, and thus they are providing more infection control products to maintain overall hygiene. China is the largest manufacturer and exporter of PPE kits in the world.

The European region is expected to register the second-highest growth rate since governments now utilize more funds to develop healthcare facilities to become global players.

North America accounted for the most significant share of the global infection control market in 2021. The U.S. is expected to have the third-highest growth rate because there is not much domestic supply of such products, and they rely on other countries for imports. However, the scenario is changing, with the government now supporting more local players.

KEY MARKET PARTICIPANTS:

Some of the prominent companies dominating the global infection control market analyzed in this report are 3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group.

RECENT HAPPENINGS IN THIS MARKET:

• In December 2018, Holchem Group Limited was acquired by Ecolab. (UK). Echolab's hygiene and cleaning product and service range for the food and beverage, food service, and hospitality sectors was improved due to this acquisition.
• In November 2018, Omnia S.p.A. was acquired by Cantel Medical. (Italy). Cantel's position in the dental infection prevention market in Italy and other European countries was strengthened by the acquisition of Omnia, a dental surgical consumables business.
• In September 2018, Getinge (Sweden) introduced the S-8668T Washer Disinfector. (a new addition to the Getinge 86 Series).
• In February 2017, Getinge (Sweden) and Ultra Clean Systems, Inc. (the US) signed an agreement under which Getinge would sell Ultra Clean Systems' hospital-grade ultrasonic cleaning devices, accessories, and detergents to healthcare facilities in the United States and Canada.